BAUSCH HEALTH AMERICAS, INC.
An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects
- First Posted Date
- 2017-08-07
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT03240809
- Locations
- 🇺🇸
Bausch Site 005, Henderson, Nevada, United States
🇺🇸Bausch Site 003, San Diego, California, United States
🇺🇸Bausch Site 002, Miami, Florida, United States
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2017-05-31
- Last Posted Date
- 2021-11-10
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 741
- Registration Number
- NCT03170388
- Locations
- 🇺🇸
Valeant Site 22, Detroit, Michigan, United States
🇺🇸Valeant Site 31, Nashville, Tennessee, United States
🇺🇸Valeant Site 26, New York, New York, United States
A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)
- Conditions
- Interventions
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 801
- Registration Number
- NCT03168334
- Locations
- 🇺🇸
Valeant Site 39, Sugar Land, Texas, United States
🇺🇸Valeant Site 07, Dallas, Texas, United States
🇺🇸Valeant Site 33, Stony Brook, New York, United States
A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)
- Conditions
- Interventions
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 813
- Registration Number
- NCT03168321
- Locations
- 🇺🇸
Valeant Site 27, Pembroke Pines, Florida, United States
🇺🇸Valeant Site 36, New York, New York, United States
🇺🇸Valeant Site 26, Newnan, Georgia, United States
An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation
- Conditions
- Interventions
- First Posted Date
- 2017-04-19
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 124
- Registration Number
- NCT03120520
- Locations
- 🇺🇸
Synergy Research Site, Newport News, Virginia, United States
Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability
- First Posted Date
- 2017-02-24
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT03063489
- Locations
- 🇺🇸
Valeant Site 03, Oceanside, California, United States
🇺🇸Valeant Site 05, Miami, Florida, United States
🇺🇸Valeant Site 06, Kansas City, Missouri, United States
Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2017-06-09
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT03058744
- Locations
- 🇺🇸
Valeant Site 05, Encino, California, United States
🇺🇸Valeant Site 06, New York, New York, United States
🇺🇸Valeant Site 01, San Diego, California, United States
Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
- Conditions
- Interventions
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 328
- Registration Number
- NCT03058783
- Locations
- 🇺🇸
Valeant Site 05, Fremont, California, United States
Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2016-12-26
- Last Posted Date
- 2017-12-18
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 364
- Registration Number
- NCT03003247
- Locations
- 🇺🇸
Valeant Site 15, Encino, California, United States
🇺🇸Valeant Site 13, Lake Mary, Florida, United States
🇺🇸Valeant Site 14, Tampa, Florida, United States
Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)
- Conditions
- Interventions
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 338
- Registration Number
- NCT03002571
- Locations
- 🇺🇸
Valeant Site 01, Fort Lauderdale, Florida, United States